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the former. So far various efforts have been made towards characterizing
these processes, yet there are still aspects that remain to be clarified. Previous
metadynamics analysis, as well as other independent studies, of the equilib-
rium conduction mechanism in NavAb point to a two-ion mechanism, de-
coupled from other incoming ions and water molecules. From the 0 mV
potential of mean force (pmf) relative to the two-ion conduction through
the channel SF, we analytically evaluate the pmf’s dependence on applied
voltage potential (V). When small V is applied biased and unbiased pmfs
are overall similar. Contrastingly, under higher V conditions, an excess free
energy arising from the applied external potential causes an asymmetry
between hyper (V<0) and depolarized (V>0) conduction free energy surfaces
and hence alters conduction mechanism. These results agree with MD studies
explicitly considering the influence of transmembrane potentials. Same anal-
ysis has been applied to a similar system containing two Kþ inside the NavAb
SF. We next aimed at further glancing at the channel conduction and selec-
tivity, by characterizing the kinetics of the process by means of transition state
theory. Surprisingly however, under higher voltages, the kinetic model highly
overestimate the expected conductance of the channel. We are now faced with
the question as to whether the TST model is inaccurate (though it has been
previously shown to work), or whether deeper issues, such as mistaking the
heights of barriers in the relatively confined SF environment are also playing
a role.
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The voltage sensor module comprises the positively charged S4 residues and
negative countercharges in S1 to S3 segments. In the present study the puta-
tive interaction of these charges in domain IV during fast inactivation of the
human voltage gated sodium channel of skeletal muscle was investigated. The
effects of charge reversing mutations of R1448 and R1457 were compared to
those for mutations at N1366, E1373, N1389 and D1420. Mutations slowed
the entry of channels into fast inactivation, slowed or accelerated the recovery
of channels from fast inactivation, and reduced the gating charge. Charge
swapping mutations had a more pronounced effect to rescue the wild type
phenotype on recovery from fast inactivation than for entry into fast inactiva-
tion. These results suggest specific residue interactions that promote S4 trans-
location during the deactivating transition leading to recovery from the fast
inactivated state.
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The bacterial sodium channel NaChBac is a prokaryotic ancestor of eukary-
otic voltage-gated sodium channels (Nav), which are critical for action
potential generation and propagation in nervous and cardiac tissue. Like
all mammalian Nav isoforms examined thus far, NaChBac is inhibited by
clinically relevant concentrations of the inhaled volatile anesthetic isoflurane,
and inhibition is accompanied by enhancement of slow or C-type inactivation
(Ouyang et al., 2007). However, a detailed mechanistic explanation of the
interplay between C-type inactivation and isoflurane inhibition is lacking.
To shed light on the relationship between inactivation and inhibition,
we introduced point mutations known to alter inactivation in NaChBac
(G219A, G219P, G229A, and S195E), expressed the channels in HEK293FT
cells, and applied isoflurane during whole-cell patch clamp recording.
Preliminary data support the idea that isoflurane acts by multiple mechanisms
invovling multiple sites on NaChBac. Channel mutations that enhance
inactivation show greater current reduction by isoflurane, suggesting that
isoflurane binds more favorably to inactivated channels. However, isoflurane
exhibits both tonic and use-dependent block of the essentially non-
inactivating NaChBac G219P mutant, indicating that binding also occurs
in the closed/resting and open/conducting states. A detailed biophysical
and pharmacological profile of these NaChBac inactivation variants together
with a recent molecular dynamics simulation study showing isoflurane inter-
acting with NaChBac at three distinct binding sites (Carnavale et al, 2013)
supports multiple mechanisms of state-dependent inhibtion. Such functional
data help clarify the complex pharmacological effects of volatile anesthetics
on Nav channels, and contribute to better understanding of C-type inactiva-
tion in these proteins.
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Recent breakthroughs in the structure determination of the bacterial voltage-
gated sodium channel NavAb have revealed the full length Nav channel for
the first time at atomic resolution. However, additional structures of Nav chan-
nels in different conformational states are still needed for further understanding
of the conformational changes that take place in Nav channels during channel
gating. Specifically, full-length structures of Nav channels in the resting state,
open state, inactivated state, and drug-bound conformations are still missing. In
our search for ligands that confine Nav channels in one of these conformational
states we have turned our attention to cinnamaldehyde. We tested cinnamalde-
hyde, a compound that affects different subtypes of eukaryote Nav channels, on
the bacterial Nav channel NaChBac expressed in Xenopus oocytes. Our results
indicate that cinnamaldehyde has a dual effect on NaChBac: cinnamaldehyde
not only decreases the peak current but also accelerates channel inactivation
of this bacterial Nav channel in a concentration-dependent manner. Our record-
ings indicate that cinnamaldehyde stabilizes NaChBac in an inactivated state.
This opens up perspectives to employ cinnamaldehyde as a molecular tool to
aid crystallization of bacterial Nav channels in an inactivated conformation.
We expect that such a structure could give important insight into the conforma-
tional changes that contribute to channel inactivation.680-Pos Board B435
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Automated patch clamping is well established within academic research and
drug discovery efforts. Still, there is a longstanding desire to have gold stan-
dard electrophysiology compatible with primary ion channel drug screening
requirements. We here present a chip-based approach for massively parallel
patch clamp recordings. Using microstructured glass bottom microtitre plates,
recordings from 384 cells are performed in an automated fashion. The
recording system contains 384 patch clamp amplifiers and is integrated into
a liquid handling robot with 384 channel pipettor, so all experiments are
done completely in parallel. Success rates achieved are routinely over 85%.
A full run of 384 cells for dose response analysis takes less than 15 minutes,
delivering several thousand data points
per hour.
The figure below shows a screenshot of an
experiment on 384 CHO cells expressing
Kv1.3 channels. (Raw current responses
to a voltage step protocol). In this presenta-
tion, recordings from various ligand- and
voltage-gated ion channels on the 384
channel platform will be shown.681-Pos Board B436
Sodium Channel Peptide Neurotoxin Studies Using a High Throughput
Electrophysiology Platform and Very Long Assay Windows
Xin Jiang, Jeffrey Webber, Trisha Mitlo, Edward Verdonk, James Costantin.
Molecular Devices, LLC, Sunnyvale, CA, USA.
Neurotoxins identified in various animal venoms have long been used for
studying ion channel structure and function, due to the high binding affinity
of toxins to ion channels. Over the years, peptide neurotoxins have also
attracted great interest as potential strategies for treatment of ion channel-
related diseases. Despite the growing need of developing peptide toxins as
drug candidates, the high-throughput analysis of peptide toxin can be chal-
lenging, as the toxins are typically large molecules with relatively slower
binding-rate to the channel targets (compared to small molecule compounds).
In addition, the binding affinities of these toxins to the channel are often
state-dependent. Taken together, to successfully assay these toxins an assay
platform needs to provide: 1) A long and stable assay window to capture the
full association kinetics of the toxins, 2) Sophisticated voltage protocols to
drive channels into desired conformational states, and 3) Adequate throughput
and low running cost requirements of a drug screening environment. In this
